Immunohistochemistry Doctors Abroad — Page 3

Dr. Viktor Alexander Krol is the Chief Physician of Gastroenterology and Internal Medicine at St. Martinus-Krankenhaus Düsseldorf. He also directs a certified Obesity Treatment Center. Dr. Krol treats complex diseases of the digestive tract, metabolism, and respiratory system. He works at one of only two German clinics accredited by the International Federation of Obesity.

• Performs bariatric surgeries and endoscopic weight loss procedures.
• Treats gastrointestinal conditions like pancreatitis, Crohn's disease, and cirrhosis.
• Manages internal medicine cases across cardiology, diabetology, and nephrology.
• Uses diagnostic tools including gastroscopy with biopsy and endosonography.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Professor Johannes Drach specializes in hematology and oncology at the Goldenes Kreuz Private Hospital. This diagnostic supports his work in identifying leukemia and solid tumors.

• Director of the Josefstadt Private Clinic with leadership in oncologic diagnostics
• Trained at MD Anderson Cancer Center – a world leader in cancer research
• Authored 120+ scientific papers on blood disorders and chromosomal changes
• Board Member of the Austrian Society of Hematology and Oncology
• Former Director of the Multiple Myeloma and Malignant Lymphoma program

Associate Professor Tahsin Ozatli is an oncologist at Istinye Liv University Hospital. He specializes in identifying and treating lung, breast, and gastrointestinal cancers.

• Expert in immunohistochemistry used to identify specific cancer subtypes for targeted treatment
• Previously served as a physician at the Ankara Oncology Clinic in Turkey
• Served in the oncology department at Erzurum Regional Training and Research Hospital
• Completed medical training at Selcuk University Faculty of Medicine
• Achieved the rank of Associate Professor in oncology in 2016

Dr. Séverine Iborra is the Chief Physician of Gynecology and Obstetrics at the Medical Center in Solingen. She specializes in gynecological oncology and high-risk perinatal medicine. Dr. Iborra uses the Da Vinci robotic system for minimally invasive cancer surgeries. She is a certified specialist in cervical pathology and urogynecology.

• Performs robotic hysterectomies and myomectomies with high precision.
• Treats complex cancers of the breast, ovaries, and cervix.
• Certified by the Gynecological Oncology Working Group in diagnostics and therapy.
• Leads a department at a clinic ranked among the top in Germany by Focus magazine.

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Gal Goldstein leads the Department of Pediatric Oncology at Hadassah Hospital. He uses immunohistochemistry to identify specific antigens and tailor cancer treatments for children.

• Forbes listed him among the best doctors in Israel
• Heads the pediatric oncology and hemato-oncology division at Hadassah Hospital
• Specializes in precision medicine for solid tumors and complex blood disorders
• Member of SIOP – an international group setting pediatric oncology standards
• Earned his medical degree from the prestigious Tel Aviv University

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Professor Beni Boursi is a high-level oncology specialist at Sheba Medical Center. He uses immunohistochemistry to identify specific cancer proteins for targeted treatment planning.

• Completed subspecialty training in oncology at the University of Pennsylvania
• Trained at MD Anderson and Mayo Clinic in the United States
• Works in the Gastrointestinal Cancer Department at Israel's largest hospital
• Published research in Science and other top-tier medical journals
• Member of the American Society for Cancer Research

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.